.-Chemical and chromatographic fractions of disrupted Mycoplasma pneumoniae organisms were examined for serological and immunogenic activity. Complement-fixing activity was associated with lipid components, whereas precipitin activity was chiefly associated with polysaccharide components. When chemically extracted lipids were separated by thin-layer silica gel chromatography, only three of the nine fractions exhibited complement-fixing activity. Although lipids were highly active serologically, they were only weakly immunogenic. However, lipids combined with protein in lipoprotein complexes were highly immunogenic, stimulating high levels of complement-fixing, indirecthemagglutinating, and growth-inhibiting antibodies. The specificity of these antibodies was directed chiefly against the serologically active lipid constituents of the organism. It was suggested that these serologically active lipids are present at the sites on the limiting membrane of M. pneumoniae at which antibody acts to inhibit growth of the organism. Only protein fractions adsorbed to tanned erythrocytes. The main function of protein in the indirect-hemagglutination reaction appeared to be that of serving as a carrier for the serologically active lipids.
In the accompanying report, we described the separation of Mycoplasma pneumoniae into a number of chemical and chromatographic fractions (10) . Chemical extraction of the organism yielded one lipid fraction, three protein fractions, and four polysaccharide fractions. The major protein fraction was found to contain a small quantity of lipid. Four separate fractions were obtained when the supernatant fluid from a sonically disrupted suspension of organisms was chromatographed on a Sephadex G-25 column. These fractions contained mostly protein and some polysaccharides, and the one fraction tested for lipid was found to contain 15 % of such material.
This portion of the study was initiated to determine the nature of the various antigens of M.
1 World Health Organization Fellow from the Institute of Epidemiology and Microbiology, Prague, Czechoslovakia. pneumoniae which react in the different serological procedures used for assay of antibody. In addition, we were interested in defining the nature of the antigens of this organism which stimulate antibodies measurable by the different serological techniques. Such information would have relevance to our basic understanding of this important respiratory-tract pathogen, and to the future preparation of purified vaccines containing only those antigens which stimulate protective antibodies.
MATERIALS AND METHODS M. pneumoniae strain. The FH strain of M. pneumoniae was isolated in embryonated eggs by Liu from a patient with atypical pneumonia (9) . The organism was subsequently passaged 305 times in artificial cellfree media in this laboratory (2) . Harvests from the 295th passage through the 305th passage were used for this study.
Cultivation medium for preparation ofcrude starting 2126 FRACTIONS OF M. PNEUMONIAE. I2 material and methods of fractionation. The methods used for cultivation of M. pnewnoniiae were described in the preceding paper (10) . The procedures used for chemical fractionation and Sephadex chromatography were also described in the preceding paper (10) .
Complement-fixation test. Lyophilized M. pneumoniae fractions obtained by means of chemical or chromatographic fractionation were prepared as 1% solutions or suspensions in phosphate-buffered saline (PBS) and then tested for complement-fixing activity. Lipid fractions were dissolved in a small amount of propylene glycol before these materials were diluted to 1% in PBS. All fractions were tested by the micro complement-fixation technique (11) . Two exact units of complement were used. The antigen-serum-complement mixtures were incubated overnight at 4 C prior to addition of sensitized erythrocytes.
The preparation of standard M. pneumoniae antigen was described previously (3) . Briefly, organisms (FH strain) were grown aerobically in broth medium at 34 C for 16 days, and then 0.5% phenol was added and the suspension was reincubated for an additional 4 days. The suspension was then heated at 56 C for 30 min, and this material constituted the complementfixing antigen.
Indirect-hemagglutination test. The M. pneumoniae fractions tested by complement fixation were also tested for their capacity to sensitize tanned sheep red cells (6, 12) . For purposes of comparison, a sonically treated suspension of whole organisms was also tested for indirect-hemagglutination activity.
The method of sensitization of tanned sheep red blood cells and of antigen titration, ard the technique of the indirect hemagglutination test were described in detail previously (12 Serial twofold dilutions of each fraction were made in test tubes and to each dilution was added an equal volume of M. pneumoniae rabbit antiserum diluted to contain 8 units of indirect hemagglutinating antibody. The diluent was normal rabbit serum diluted 1: 200 in PBS. The same serum dilution mixed with the diluent was used for a control. The mixtures were then incubated, with occasional shaking, for 1 hr at 37 C. Then each of the mixtures was transferred in 0.025-ml amounts into microtiter disposable plates (with "V"-shaped cups) by use of a microtiter dropper. A volume of 0.025 ml of tanned sheep red blood cells sensitized with a sonically treated suspension of whole organisms was then added to each cup. The plates were then sealed with Scotch cellophane tape and incubated for 2 hr at 34 C.
The highest dilution of a fraction which inhibited 75 to 100% of the agglutinating activity produced by 8 units of antibody was considered as 1 unit of inhibitory activity. Growth-inhibition test (tetrazolium reduction inhibition test). The test was a modification of that described by Jensen (Bacteriol. Proc., p. [70] [71] 1964) . It was performed in disposable microtiter plates with "U"-shaped cups. Heat-inactivated (56 C, 30 min) serum was diluted in twofold steps in 0.025-ml quantities by use of microtiter loops. The diluent consisted of the broth medium used for cultivation of M. pneumoniae, except that glucose and phenol red were omitted, and 2, 3, 5-triphenyltetrazolium chloride was added to a final concentration of 0.05%. An inoculum of 0.025 ml of M. pneumoniae (FH strain, passage 227) was then added with a microtiter dropper to each cup, followed by a final 0.15 ml of the medium. The plates were then sealed with Scotch cellophane tape, wrapped in tin foil to prevent light penetration, and incubated at 34 C. The inoculum was a stock frozen (-70 C) suspension of M. pneumoniae diluted in broth medium to a concentration of approximately 104 colony-forming units (CFU) per 0.025 ml. The suspension of organisms was titrated at the time of each test, and a standard M. pneumoniae human convalescent serum was included in each test as a positive serum control. The results of the test were recorded when the dilution of the organisms used in the test reduced tetrazolium, and when an indicated dilution of the standard serum inhibited growth of the organisms. This occurred with the above-mentioned inoculum after 5 then incubated, with occasional shaking, for 1 hr at 37 C. Then 0.025-ml quantities of each of the fractionserum mixtures were transferred into microtiter disposable plates ("U"-shaped cups) by use of a microdropper. The cups were then inoculated with 0.025 ml of a suspension containing approximately 104 CFU of M. pneumoniae (FH strain, passage 227). Finally, 0.15 ml of broth medium was added to each cup; the plates were then sealed with Scotch cellophane tape and wrapped in tin foil to prevent light penetration. Incubation was at 34 C. A titration of the inoculum was performed at the time of each test.
Results were recorded when the dilution of organnisms used in the test reduced tetrazolium, and when 8 units of antibody inhibited this reduction. The highest dilution of a fraction capable of blocking the growth-inhibitory activity of 8 Two rabbit hyperimmune antisera were used in this study. The first antiserum was used to measure the complement-fixing and indirect-hemagglutination activity of the various fractions. It was also used in the antibody-blocking tests. This antiserum was prepared by repeated injection of rabbits with an M. pneumoniae-infected chick embryo lung suspension. This serum did not contain antibodies for the medium constituents present in the broth medium used for the cultivation of M. pneumoniae, but did contain high levels of M. pneumoniae antibodies measurable by complement fixation (1:1,024), indirect hemagglutination (1:2,048 to 1:4,096), and growth inhibition (1:20,480). The serum exhibited a heterotypic complement-fixation reaction with only one of the other human mycoplasma species (M. salivarium), and in this instance the heterotypic serum titer (1:64) was considerably lower than the homotypic titer (1:1,024). The maximal heterotypic indirect hemagglutination reactions exhibited by the serum were low (1:20) when compared with the homologous titer (1:2,048 to 1:4,096). Indirect hemagglutination antigens were prepared from sonically disrupted organisms; thus, internal as well as extemal components were available as antigens in this test.
The second rabbit antiserum was used for the agar gel-diffusion studies. Rabbits were immunized with a suspension of M. pneumoniae grown in rabbit infusion broth supplemented with rabbit serum. The antiserum produced three precipitin lines in agar gel when tested with a concentrated suspension (800 times) of disrupted M. pneumoniae. The serum did not produce precipitin lines when tested with concentrated suspensions (800 times) of disrupted heterotypic organisms which were reactive (three or more precipitin lines) with their homologous antisera.
In the complement-fixation, indirect-hemagglutination, and growth-inhibition tests, the M. pneumoniae immune sera were used at a dilution which was eightfold greater than the serum end point. At these dilutions, the antisera did not exhibit heterotypic reactivity.
Immuniization of animals with M. pneumoniae fractions. Antisera to the fractions of M. pneumoniae were produced in rabbits and guinea pigs. For immunization, 1 % suspensions or solutions of the lyophilized fractions in PBS were used.
Rabbits were injected intradermally at multiple sites with a mixture of 1 ml of fraction and 1 ml of complete Freund's adjuvant. The same volume of injected material, but mixed with incomplete adjuvant, was given intradermally 3 weeks later. After an additional 3-week interval, 1 ml of fraction was injected intraperitoneally, and the animals were bled out 1 week later.
The method for guinea pig immunization was essentially the same, except that the material injected consisted of 0.5 ml of M. pneumoniae fractions and 0.5 ml of adjuvant. For purposes of comparison, guinea pigs were also immunized with 1 and 10% suspensions of M. pneumoniae disrupted by sonic treatment.
RESULTS
Antigenic activity offractions. The various fractions extracted from M. pneumoniae were tested for their activity in the complement-fixation and indirect-hemagglutination reactions. In addition, they were tested for their capacity to block the effect of indirect-hemagglutinating and growthinhibiting antibodies.
Chemical fractions. After sonic treatment of M. pneumoniae at 10 kc for 1 hr, the suspension was centrifuged at 63,000 X g for 1 hr. The resulting sediment was then treated as indicated in the preceding paper, and a series of fractions were obtained. With one exception (polysaccharide frac-tion 1), complement-fixing activity was demon-chromatography of the chemically extracted lipid strated only in those fractions which contained fraction lacked complement-fixing activity. Similipid (Table 1) . Not all lipid fractions, however, larly, three of the five fractions obtained after exhibited complement-fixing activity. Six of the thin-layer chromatography of the lipids extracted nine fractions obtained after silica gel thin-layer from the Sephadex G-25 fraction 1 lacked com- Fractions 1 and 2 were active in combining with growth-inhibiting antibody, whereas fractions 3 and 4 were not. Lipid appeared to be responsible for the antibody-blocking activity of fraction 1, since removal of lipid from this fraction led to a complete loss of reactivity with growthinhibitory antibodies.
On a dry-weight basis, the complement-fixation indirect-hemagglutination, and antibody-combining activities of the Sephadex G-25 fraction 1 and its rechromatographed fraction were similar to those of the starting material. This suggests that the active components of the organism were not selectively concentrated by chromatography on the Sephadex G-25 or G-100 column.
Recovery of serological activity in the various fractions. After chemical or chromatographic fractionation of a sonically treated suspension of M. pneumoniae, almost all of the complementfixing activity was recovered in four fractionsthe lipid fraction and protein fraction 2 derived from the sediment of the M. pneumoniae suspension, and the Sephadex G-25 fractions 1 and 2 derived from the supernatant fluid of the suspension. Similarly, almost all of the growth-inhibitory antibody-combining activity was recovered in these four fractions. Approximately 45% of the CF activity of the starting material was recovered in these fractions (Table 3) . Recovery of growthinhibitory antibody-combining activity in these fractions was somewhat less (25%). It should be emphasized that these values are only approximate, since the error of the titration procedures is at least two-fold. Despite this source of error, it would appear that considerably more complement-fixing and growth-inhibitory antibodyblocking activities were recovered in the chromatographic fractions (derived from the supernatant fluid of the sonically treated M. pneumoniae suspension) than in the chemical fractions (derived from the sediment of the sonically treated suspension).
Comparison of several fractions by complement fixation. In the first paper of this series, it was shown that the lipids extracted from the sediment of the sonically treated organisms, from Sephadex G-25 fraction 1, and from protein fraction 2 exhibited some chromatographic similarities. After silica gel thin-layer chromatography, each of these extracts was found to separate into five to nine discrete fractions. The lipid extract of the sediment of the sonically treated organisms yielded nine fractions, but only the first three exhibited complement-fixing activity (Table 1) . When the first of the fractions was rechromatographed on silica gel, four separate fractions were obtained. Rechromatography of the first fraction from the lipid of Sephadex G-25 fraction 1 yielded only three fractions. However, these fractions appeared to be identical to three of the fractions obtained after rechromatography of the first fraction of the lipid from the sediment of the sonically treated organisms.
The relationships of the lipid fractions were examined further by complement fixation. The lipids and the materials from which they were extracted were cross-tested by use of antisera prepared against the lipid fraction from the sediment of the sonically treated organisms, Sephadex G-25 fraction 1, and protein fraction 2.
The lipid extract from the sediment of the sonically treated organisms and that obtained from the Sephadex G-25 fraction 1 appeared to be closely related antigenically (Table 4 ). The former lipids were distinct serologically from the lipids of protein fraction 2. The Sephadex G-25 fraction 1 lipids exhibited a one-way relationship with the lipids of protein fraction 2; antiserum to the former reacted with the latter antigen, but not The suspension of whole organisms produced three precipitation lines in agar gel. For convenience, we have designated these lines A, B, and C. Three of the five chromatographic fractions tested produced precipitation lines. Sephadex G-25 fraction 1 and this fraction rechromatographed on Sephadex G-100 each produced three precipitation lines. Sephadex G-25 fraction 2 produced two lines, whereas fractions 3 and 4 did not produce a reaction in agar gel. The three lines of both Sephadex G-25 fraction 1 and its rechromatographed fraction gave reactions of identity with lines A, B, and C produced by the sonically treated suspension of whole organisms. The two lines produced by Sephadex G-25 fraction 2 exhibited reactions of identity with lines A and B.
Three of the chemically extracted fractions produced a precipitin reaction in agar gel. The lipid extract (from the sediment of the sonically treated organisms) produced one precipitation line which was transient. This line developed approximately 5 hr after the lipid fraction was added to the agar; however, the line was not detectable 24 hr later. Protein fraction 2 produced one line which persisted. Polysaccharide fraction 2 produced two precipitation lines, both of which persisted. The other five chemical fractions tested-polysaccharide fractions 1, 3, and 4, and protein fractions 1 and 3-did not produce precipitation lines.
The line produced by protein fraction 2 gave a reaction of identity with line A of the sonically treated organism suspension. The lines of polysaccharide fraction 2 were related to, but not identical with, lines B and C of the sonically treated organism suspension. When polysaccharide fraction 2 and the sonically treated organism suspension were placed in adjacent cups, the two lines produced by the former material were not continuous with lines B and C; instead, spurring was observed.
Because of its transient nature, the line produced by the lipid extract (from the sediment of the sonically treated organisms) was difficult to compare with the precipitation lines produced by the other fractions. In one test, the lipid precipitin was shown to be distinct from the two polysaccharide precipitins. The relationship of the lipid precipitin to the other precipitating antigens was not tested successfully.
Immunogenic activity. Eight chemically extracted fractions and four chromatographic fractions were tested for their capacity to stimulate the production of complement-fixing indirecthemagglutinating, and growth-inhibiting antibodies in animals. In addition, protein fraction 2 chromatographed on Sephadex G-25 and the rechromatographed Sephadex G-25 fraction 1 (Sephadex G-100) were studied. All of the fractions were injected into guinea pigs, whereas only five fractions were tested in rabbits. High levels of complement-fixing antibodies, i.e., 1:256 to 1:1,024 or greater, were stimulated by polysaccharide fraction 1, protein fraction 2 chromatographed on Sephadex G-25, Sephadex G-25 fraction 1 and its rechromatographed fraction (Sephadex G-100), and Sephadex G-25 fractions 2, 3, and 4 (Table 5 ). In several instances, a high titer of complement-fixing antibody developed for the homologous (i.e., the immunizing) antigen but not for the standard antigen; this phenomenon was observed with the chromatographed protein fraction 2, the Sephadex G-25 fraction 1, and its rechromatographed fraction, and Sephadex G-25 fraction 4. These differences may reflect a difference in the quantitative or spatial distribution of active components in the immunizing material and in the standard complement-fixing antigen.
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Moderate levels ofcomplement-fixing antibody, i.e., 1:32 to 1:128, were stimulated by protein fractions 1 and 2. It is of interest that the lipid fraction, which was the most active material in the complement-fixation reaction, stimulated complement-fixing antibody in only one of six injected animals. One of two rabbits developed a moderate level of complement-fixing antibody, whereas two guinea pigs shown in Table 6 Table 6 . Using these data, we will attempt to describe the nature of the components responsible for various antigenic and immunogenic activities of the organism. It should be emphasized that the chemical fractionation procedure offered a number of opportunities for antigens to be denatured and for antigens to be artificially partitioned between fractions.
Complement-fixing activity of M. pneumoniae were associated predominantly with its lipid components. These findings are consistent with those of Kenny, who extracted complement-fixing antigen from M. pneumoniae with several lipid solvents (8) . In addition, we found that the first polysaccharide fraction, which was lipid-free, exhibited a low level of complement-fixing activity when tested with hyperimmune rabbit serum. However, this fraction did not react with convalescent human serum. Several of the protein-containing fractions (protein fraction 2 and Sephadex G-25 fraction 1) exhibited complementfixing activity, but this activity was produced by the lipid components of these fractions. When lipids were removed from these fractions, complement-fixing activity was lost.
When examined by thin-layer chromatography, the lipid extract of the sediment of the sonically treated organisms separated into nine discrete fractions. Only the first three of the fractions exhibited complement-fixing activity. It is of interest that these three fractions did not contain cholesterol, which is a major constituent of sterol-requiring mycoplasmas. Preliminary analysis indicates that the three active fractions contain phospholipids. The first of the active thin-layer chromatographic fractions was not homogeneous, since rechromatography on silica gel yielded four discrete fractions.
After thin-layer chromatography, the lipids from protein fraction 2 and Sephadex G-25 fraction 1 each yielded fractions which corresponded to the serologically active first and third fractions obtained from the lipid extract derived from the sediment of the sonically treated organisms. This resemblance was more than chromatographic, since the fractions separated from the lipids of Sephadex G-25 fraction 1 which corresponded to the serologically active fractions of the lipids from the sonically treated organisms also exhibited complement-fixing activity.
Chemically extracted lipids did not adsorb to tanned sheep erythrocytes. However, lipid appeared to be involved in the indirect hemagglutination reaction, since the lipids active in complement fixation also combined with and blocked the action of the antibodies which agglutinate 2136 J. BACTERIOL. sensitized red cells. Although protein by itself was capable of adsorbing to tanned erythrocytes, it was less important than lipid in the reaction with agglutinating antibodies. Thus, the reactive lipid fractions were more active in inhibiting indirect hemagglutination, on a weight basis, than was protein free from lipid. Also, protein fraction 2 and Sephadex G-25 fraction 1 lost considerable indirect-hemagglutination activity when lipids were removed from these fractions. Taken together, these findings suggest that the sensitizing moiety in the indirect hemagglutination reaction is a lipoprotein; the protein component is probably responsible for adsorption to tanned red cells, whereas the lipid component is mainly responsible for the reaction with specific agglutinating antibodies. Tully previously described sensitization of erythrocytes with protein extracts from a number of different mycoplasmas (13) .
The lipid components which are active in complement fixation and which react with indirecthemagglutinating antibody also appear to be present at the sites at which antibodies produce a growth-inhibitory effect. Thus, polysaccharide fractions and protein fractions free from lipid did not react with growth-inhibitory antibodies, whereas fractions containing serologically active lipid components blocked the growth-inhibitory effect of antiserum.
The chemically extracted (purified) lipid fraction which exhibited marked in vitro serological activity was weakly immunogenic after injection of rabbits and guinea pigs. Low-level stimulation of complement-fixing and indirect-hemagglutinating antibodies was observed, but growth-inhibitory antibody did not develop. The poor immunogenicity of these lipids is not surprising, since lipids in general are known to be ineffective stimulators of antibody (7) . In contrast to purified lipids, lipids bound to proteins in lipoprotein complexes (Sephadex G-25 fraction 1 and protein fraction 2) were found to be moderately or highly immunogenic. Moderate levels of growth-inhibitory antibodies and high levels of complementfixing and indirect-hemagglutinating antibodies were stimulated by the lipoprotein-containing Sephadex G-25 fraction 1. It should be emphasized that the specificity of the growth-inhibitory antibodies was directed against the lipid components of the lipoprotein complex. It is probable that growth-inhibitory antibodies act upon the limiting membrane of the organism. For this reason, it is likely that the lipoproteins which react with growth-inhibitory antibodies occupy a peripheral position on the organism-most likely on the triple-layered unit membrane which surrounds the organism (5) .
Polysaccharide fractions were not active in complement fixation except for fraction 1, which exhibited low-level activity. The polysaccharide fractions did not participate to a significant extent in the indirect-hemagglutination reaction. Furthermore, the fractions did not react with growthinhibitory antibody. The major activity of the polysaccharides was exhibited in the precipitation reaction. Similar findings have been reported for polysaccharides extracted from M. mycoides (14) . In the present experiments, polysaccharide fraction 2 produced two precipitation lines when tested by the agar gel-diffusion technique. Chemically extracted lipid (from the sediment of the sonically treated organisms) and protein fraction 2 each produced only one precipitation line. The lipid precipitin was completely distinct from the two polysaccharide precipitins. A sonically treated suspension of the whole organism produced three precipitation lines in agar gel, and two of these lines appeared to be related to the precipitation lines produced by polysaccharide fraction 2. Protein fraction 2 initially exhibited complement-fixing activity, but this was lost when lipid was removed from the fraction. Protein, free from lipid, could sensitize tanned sheep red cells, but for maximal indirect-hemagglutinating activity a lipoprotein complex was required. The main function of protein in the indirect-hemagglutination reaction appears to be that of serving as a carrier for the active lipid components. Protein probably serves a similar function in contributing to the immunogenicity of the active lipids.
The first two fractions recovered from the Sephadex G-25 column exhibited a high level of reactivity in the complement-fixation and indirecthemagglutination reactions. These fractions also combined effectively with growth-inhibitory antibodies, and were the only fractions which stimulated moderate levels of such antibodies in guinea pigs and rabbits. In each of these serological and immunogenic activities, the first two chromatographic fractions were considerably more potent than the chemically extracted protein fraction, which contained a small quantity of lipid (2%). The finding that the first and second chromatographic fractions stimulated the development of growth-inhibitory antibodies is significant. Previously, we have shown that growth-inhibitory antibodies correlate well with resistance to M. pneumoniae illness (1) . Possibly, chromatographic techniques similar to those used in this study may prove useful in the development of a purified, inactivated M. pneumoniae vaccine for the prevention of cold agglutinin-positive atypical pneumoniae.
